Integrating DNA-encoded chemical libraries with virtual combinatorial library screening: Optimizing a PARP10 inhibitor

Bioorg Med Chem Lett. 2020 Oct 1;30(19):127464. doi: 10.1016/j.bmcl.2020.127464. Epub 2020 Aug 5.

Abstract

Two critical steps in drug development are 1) the discovery of molecules that have the desired effects on a target, and 2) the optimization of such molecules into lead compounds with the required potency and pharmacokinetic properties for translation. DNA-encoded chemical libraries (DECLs) can nowadays yield hits with unprecedented ease, and lead-optimization is becoming the limiting step. Here we integrate DECL screening with structure-based computational methods to streamline the development of lead compounds. The presented workflow consists of enumerating a virtual combinatorial library (VCL) derived from a DECL screening hit and using computational binding prediction to identify molecules with enhanced properties relative to the original DECL hit. As proof-of-concept demonstration, we applied this approach to identify an inhibitor of PARP10 that is more potent and druglike than the original DECL screening hit.

Keywords: Computer-guided drug discovery; DNA-encoded chemical libraries; Hit-to-lead development; Poly-(ADP-ribose) polymerase; Virtual combinatorial libraries.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Combinatorial Chemistry Techniques
  • DNA / chemistry*
  • Drug Discovery
  • Drug Evaluation, Preclinical
  • Enzyme Assays
  • Humans
  • Molecular Docking Simulation
  • Poly(ADP-ribose) Polymerases / metabolism
  • Proof of Concept Study
  • Protein Binding
  • Proto-Oncogene Proteins / antagonists & inhibitors*
  • Proto-Oncogene Proteins / metabolism
  • Small Molecule Libraries / chemistry*
  • Small Molecule Libraries / metabolism

Substances

  • Proto-Oncogene Proteins
  • Small Molecule Libraries
  • DNA
  • PARP10 protein, human
  • Poly(ADP-ribose) Polymerases